| Followers | 66 |
| Posts | 10174 |
| Boards Moderated | 0 |
| Alias Born | 03/29/2015 |
Tuesday, April 21, 2015 8:56:25 AM
NWBO is not a cactus and thus needs watering.
So now we're really looking at August/September for news?
I hope not.
Woodford will have to work overtime to overcome a news drought that long.
I was wrong about ASCO but nonetheless I still have the effrontery to suggest some news items that are at least possible before August/September:
1. News on EAMS from the UK. What is our status on the second part of the application?
2. News on HE in from Germany. By the way, can anyone refute Pyrr's claims that due to interference from the Phase 3 trial and restrictions on where product can be manufactured, HE is a dead letter from a revenue standpoint?
3. A limited partnership on Checkpoint Inhibitors on favorable terms with a Big Pharma. Ms. Powers said to ask about that again in a few months, hinting that something was in the works. Pretty soon it will have been a few months. But with no conferences...
So now we're really looking at August/September for news?
I hope not.
Woodford will have to work overtime to overcome a news drought that long.
I was wrong about ASCO but nonetheless I still have the effrontery to suggest some news items that are at least possible before August/September:
1. News on EAMS from the UK. What is our status on the second part of the application?
2. News on HE in from Germany. By the way, can anyone refute Pyrr's claims that due to interference from the Phase 3 trial and restrictions on where product can be manufactured, HE is a dead letter from a revenue standpoint?
3. A limited partnership on Checkpoint Inhibitors on favorable terms with a Big Pharma. Ms. Powers said to ask about that again in a few months, hinting that something was in the works. Pretty soon it will have been a few months. But with no conferences...
Recent NWBO News
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • InvestorsHub NewsWire • 05/11/2026 01:00:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • GlobeNewswire Inc. • 05/11/2026 12:30:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:38:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
